|
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
LPV/r-based 2-drug HAART vs
LPV/r-based 3-drug HAART: Comparable virological efficacy
and tolerability in HIV-1-infected naïve subjects (Kalead1 study) –
48-Week results
Pinola M, Carosi G, Di Perri G, et al
PDF Poster
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
Soluble immune
markers in individuals treated for 6 years with a
lopinavir/ritonavir
(LPV/./r)-based
antiretroviral (ARV) regimen
Landay A, King M, Tschampa J, et al
PDF
Poster
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
Ezetimibe Combined with
Low Dose Statin Effectively Lowers LDL in Protease Inhibitor
Treated Patients
Klibanov OM, Gaughan JP, Tedaldi EM, et al
PDF Poster
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
One-year Fat Tissue Distribution Changes in
Antiretroviral Naïve HIV-infected Patients Treated
with Lopinavir/ritonavir (LPV/r) monotherapy versus
LPV/r with zidovudine/lamivudine (AZT/3TC)
in the MONARK Trial
Delfraissy JF, Flandre P, Ngo Van P, et al
PDF Poster
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
No change in glucose tolerance with
lopinavir/ritonavir (LPV/r) + ZDV/3TC induction followed
by
LPV/r monotherapy through 96 weeks
da Silva B, King M, Dehaan M, et al
PDF Poster
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
Changes in Lipid Parameters During Treatment
with Lopinavir/ritonavir (LPV/r) Plus Zidovudine/
lamivudine (ZDV/3TC) Induction Followed by
Maintenance on LPV/r Monotherapy Compared to
Efavirenz (EFV) + ZDV/3TC Through 96 Weeks
da Silva B, Domingo P, Joly V, et al
PDF Poster
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
Single-agent Therapy with
Lopinavir/ritonavir Suppresses Plasma HIV-1
Viral Replication in HIV-
Naïve Subjects: IMANI-2 48-Week Results
Gathe Jr.
JC, Yeh RF, Mayberry C, et al
PDF Poster
PK
analysis of rifabutin given with
lopinavir/ritonavir to persons co-infected
with TB and HIV
Boulanger C, Peloquin C,
Hollender E, et al
Abstract
Therapeutic drug
monitoring of lopinavir / ritonavir
in HIV infected children
Curras V, Hocht C ,
Cacers Guido P, et al
Abstract
|
Meta-analysis of the
pharmacokinetics and efficacy of low
dose lopinavir/ritonavir (LPV/r)
Hill A., Burger D.
Abstract |
|
|
|
|
|
|
|
|
|
|